These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 20378254)

  • 1. Bevacizumab: a potential agent for prevention and treatment of hypertrophic scar.
    Diao JS; Xia WS; Guo SZ
    Burns; 2010 Nov; 36(7):1136-7. PubMed ID: 20378254
    [No Abstract]   [Full Text] [Related]  

  • 2. Bevacizumab: one treatment for all the seasons?
    Gelibter AJ; Di Segni S; Zeuli M; Cognetti F
    J Clin Oncol; 2008 Jan; 26(3):511; author reply 511-2. PubMed ID: 18202430
    [No Abstract]   [Full Text] [Related]  

  • 3. Bevacizumab: a new hope?
    Madhusudhana KC; Newsom RS
    Eye (Lond); 2009 Sep; 23(9):1755-7. PubMed ID: 19741717
    [No Abstract]   [Full Text] [Related]  

  • 4. Bevacizumab beyond progression: does this make sense?
    Ellis LM; Haller DG
    J Clin Oncol; 2008 Nov; 26(33):5313-5. PubMed ID: 18854567
    [No Abstract]   [Full Text] [Related]  

  • 5. [New medications; bevacizumab].
    Cohen AF; van Bronswijk H
    Ned Tijdschr Geneeskd; 2006 Oct; 150(40):2194-5. PubMed ID: 17061430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hearing improvement after bevacizumab for neurofibromatosis type 2.
    Diao JS; Xia WS; Guo SZ
    N Engl J Med; 2009 Oct; 361(18):1810; author reply 1810-1. PubMed ID: 19877310
    [No Abstract]   [Full Text] [Related]  

  • 7. Systemic bevacizumab treatment of a juxtapapillary retinal haemangioma.
    von Buelow M; Pape S; Hoerauf H
    Acta Ophthalmol Scand; 2007 Feb; 85(1):114-6. PubMed ID: 17244223
    [No Abstract]   [Full Text] [Related]  

  • 8. [PZ Innovation Prize for Avastin: Bevacizumab--new therapy option in colon carcinoma].
    Krankenpfl J; 2005; 43(7-10):234. PubMed ID: 16515304
    [No Abstract]   [Full Text] [Related]  

  • 9. Bevacizumab and surgery: what is the real risk?
    Cohen R; Stebbing J; Windsor A
    Future Oncol; 2009 Sep; 5(7):915-7. PubMed ID: 19792957
    [No Abstract]   [Full Text] [Related]  

  • 10. Intravitreal bevacizumab for vitreous haemorrhage.
    Jonas JB; Libondi T; von Baltz S; Vossmerbaeumer U
    Acta Ophthalmol; 2008 Aug; 86(5):585-6. PubMed ID: 18081904
    [No Abstract]   [Full Text] [Related]  

  • 11. Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer.
    Ferrara N; Hillan KJ; Gerber HP; Novotny W
    Nat Rev Drug Discov; 2004 May; 3(5):391-400. PubMed ID: 15136787
    [No Abstract]   [Full Text] [Related]  

  • 12. Complete remission of psoriasis following bevacizumab therapy for colon cancer.
    Akman A; Yilmaz E; Mutlu H; Ozdogan M
    Clin Exp Dermatol; 2009 Jul; 34(5):e202-4. PubMed ID: 19077094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal bevacizumab for branch retinal vein occlusion.
    Spandau U; Wickenhäuser A; Rensch F; Jonas J
    Acta Ophthalmol Scand; 2007 Feb; 85(1):118-9. PubMed ID: 17244225
    [No Abstract]   [Full Text] [Related]  

  • 14. Tachyphylaxis and bevacizumab.
    Avgikos KN; Horgan SE; Sivaraj RR; Hu K
    Ophthalmology; 2009 Sep; 116(9):1831-2; author reply 1832. PubMed ID: 19729101
    [No Abstract]   [Full Text] [Related]  

  • 15. Tachyphylaxis and bevacizumab.
    Ziemssen F; Neuhann IM; Voelker M
    Ophthalmology; 2009 Aug; 116(8):1591-2; author reply 1592-3. PubMed ID: 19651319
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-vascular endothelial growth factor agents for pediatric retinal diseases.
    Wykoff CC; Houston SK; Berrocal AM
    Int Ophthalmol Clin; 2011; 51(1):185-99. PubMed ID: 21139484
    [No Abstract]   [Full Text] [Related]  

  • 17. Bevacizumab tachyphylaxis.
    Falavarjani KG; Modarres M
    Ophthalmology; 2009 May; 116(5):1016-7; author reply 1017. PubMed ID: 19410964
    [No Abstract]   [Full Text] [Related]  

  • 18. Addition of bevacizumab to chemotherapy for treatment of solid tumors: similar results but different conclusions.
    Ocaña A; Amir E; Vera F; Eisenhauer EA; Tannock IF
    J Clin Oncol; 2011 Jan; 29(3):254-6. PubMed ID: 21149670
    [No Abstract]   [Full Text] [Related]  

  • 19. Bevacizumab and macular edema.
    Kumar A
    Ophthalmology; 2008 Mar; 115(3):585. PubMed ID: 18319106
    [No Abstract]   [Full Text] [Related]  

  • 20. Bevacizumab in advanced lung cancer: in search of the right drug for the right patient.
    Burns TF; Juergens RA
    Oncology (Williston Park); 2010 Nov; 24(13):1223-4, 1226. PubMed ID: 21192562
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.